arvato services healthcare secures exclusive EUROPEAN logistics deal with LUNDBECK

International pharmaceutical company Lundbeck has appointed arvato services healthcare for the delivery of its products throughout France and Germany. arvato services healthcare - a supply chain specialist with sites in UK, France, Germany and Belgium - already manages the centralised warehousing and distribution of the entire Lundbeck product range in five other countries, including the Netherlands and Benelux.

Lundbeck previously had a separate logistics system with its own warehouse, local logistics partners agents in every country - and this structure led to an extremely complex and sometimes inefficient supply chain management system.

A European distribution solution, custom-tailored by arvato healthcare services, was set up in September 2007, providing Lundbeck with a centralised flow of goods, harmonised activities and a significant reduction in the complexity of its logistics.

The pharmaceutical manufacturer has also increased the delivery quality of European customer orders and increased data transparency.

With the rollout across Germany and France due to start on 1 June 2009, arvato services healthcare will be distributing more than 60 percent of the total European logistics volume of Lundbeck pharmaceuticals from its central European distribution centre in Harsewinkel directly to wholesalers, hospitals, pharmacies and pharmaceutical experts.

Michael Nerloe Kasebeer, supply chain manager at Lundbeck, said: “As a global company, we need partners to support us actively in achieving our goals at an international level. In arvato services healthcare, we have found such a reliable partner.

The results of this partnership have remained convincing for more than two years and will enable us to stick to our future rollout strategy. The question of when to begin the rollout in Germany and France was therefore just a matter of time for us.”

About Lundbeck:

Lundbeck is one of the largest research-based pharmaceutical companies in Denmark with branches in more than 50 countries. As the world’s leading producer of medications to treat illnesses of the central nervous system, Lundbeck markets its products in over 90 countries.